Target intelligence / Profile preview

Microbial cell membrane integrity pathway (null)

Target
null
Molecular classification
Other (Cellular pathway, not a defined single molecule or family)
01

Overview

The microbial cell membrane integrity pathway refers to the complex network of molecular mechanisms and protective responses that maintain the structure, function, and selective permeability of microbial cell membranes, particularly in bacteria and fungi[1][3][6]. Key components include essential phospholipids, membrane proteins, cell envelope stress sensors, and effector proteins (e.g., phage-shock proteins like PspA) that repair or reinforce membranes under stress[1][3][6]. This pathway is a validated target for several classes of antibiotics and antimicrobial peptides that act by disrupting membrane integrity, leading to cell death, but is not itself a singular, druggable molecular entity. Targeting the pathway can be therapeutically effective but poses selectivity and toxicity challenges due to potential off-target effects on host (mammalian) membranes[3][6].

Other names
Bacterial membrane integrity pathwayCell envelope stress response (in bacteria)Cell wall integrity pathway (often used in fungi for a related but distinct process)
02

Mechanism of action

Direct disruption of membrane lipid bilayer integrity Dissipation of the proton motive force Inhibition or inactivation of membrane-bound proteins Induction of membrane permeability/leakage, leading to cell death

03

Biological functions

Membrane stabilizationCell survivalResponse to stress (e.g., antibiotics, host immune factors)Maintenance of ion gradientsControl of permeability and selective transport
04

Disease associations

Infection (bacterial, fungal)Antimicrobial resistance (through envelope adaptation)Sepsis (due to membrane damage from immune attack or drugs)
05

Safety considerations

Off-target toxicity: Many drugs that disrupt microbial membranes can also affect mammalian cell membranesDevelopment of resistance via mutations or stress response upregulationDifficulty in achieving pathogen selectivity
06

Interacting drugs

Daptomycin (targets Gram-positive bacterial membranes)

3 more in the full profile.

07

Biomarkers

No universal biomarkers for "membrane integrity pathway" as a whole. However, resistance mutations in specific membrane proteins (e.g., mprF, pgsA) or upregulation of stress response proteins (e.g., PspA in *E. coli*) may be monitored in specific contexts

Beyond the preview

Go deeper on Microbial cell membrane integrity pathway (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cell membrane integrity pathway (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call